------------------------------ OMB APPROVAL ------------------------------ OMB Number Expires: Estimated average burden hours per response ....... 0.5 ------------------------------ SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b)* QLT Photo Therapeutics Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 746927102 (CUSIP Number) December 31, 1998 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [_] Rule 13d-1(c) [_] Rule 13d-1(d) - ---------- * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
<PAGE> CUSIP No. 13G Page of Pages ________________________________________________________________________________ 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) TAL Global Asset Management Inc. ________________________________________________________________________________ 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [_] ________________________________________________________________________________ 3. SEC USE ONLY ________________________________________________________________________________ 4. CITIZENSHIP OR PLACE OF ORGANIZATION Canada ________________________________________________________________________________ NUMBER OF 5. SOLE VOTING POWER SHARES 1,599,975 _________________________________________________________________ BENEFICIALLY 6. SHARED VOTING POWER OWNED BY N/A _________________________________________________________________ EACH 7. SOLE DISPOSITIVE POWER REPORTING 1,638,590 _________________________________________________________________ PERSON 8. SHARED DISPOSITIVE POWER WITH N/A ________________________________________________________________________________ 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,648,365 ________________________________________________________________________________ 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* [_] ________________________________________________________________________________ 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.1% ________________________________________________________________________________ 12. TYPE OF REPORTING PERSON* IA ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE> CUSIP No. 13G Page of Pages ________________________________________________________________________________ Item 1(a). Name of Issuer: QLT Photo Therapeutics Inc. ________________________________________________________________________________ Item 1(b). Address of Issuer's Principal Executive Offices: 200, 520 West 6th Avenue Vancouver, British Columbia V5Z 4H5 ________________________________________________________________________________ Item 2(a). Name of Person Filing: TAL Global Asset Management Inc. ________________________________________________________________________________ Item 2(b). Address of Principal Business Office, or if None, Residence: 1000 de la Gauchetiere West, Suite 3100 Montreal, Quebec, Canada H3B 4W5 ________________________________________________________________________________ Item 2(c). Citizenship: Canada ________________________________________________________________________________ Item 2(d). Title of Class of Securities: Common Stock ________________________________________________________________________________ Item 2(e). CUSIP Number: 746927102 ________________________________________________________________________________ Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a: (a) [_] Broker or dealer registered under Section 15 of the Exchange Act. (b) [_] Bank as defined in Section 3(a)(6) of the Exchange Act. (c) [_] Insurance company as defined in Section 3(a)(19) of the Exchange Act. (d) [_] Investment company registered under Section 8 of the Investment Company Act. (e) [X] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) [_] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) [_] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) [_] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) [_] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) [_] Group, in accordance with Rule 13d-1(b)(1)(ii)(J). If this statement is filed pursuant to Rule 13d-1(c), check this box. [_]
<PAGE> CUSIP No. 13G Page of Pages Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount beneficially owned: 1,648,365 (b) Percent of class: 6.1% (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote 1,599,975, (ii) Shared power to vote or to direct the vote N/A, (iii) Sole power to dispose or to direct the disposition of 1,638,590, (iv) Shared power to dispose or to direct the disposition of N/A ________________________________________________________________________________ Item 5. Ownership of Five Percent or Less of a Class. N/A ________________________________________________________________________________ Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the common stock of QLT Photo Therapeutics Inc. No one person's interest in the common stock of QLT Photo Therapeutics Inc. is more than five percent of the total outstanding common stock. ________________________________________________________________________________ Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. N/A ________________________________________________________________________________ Item 8. Identification and Classification of Members of the Group. N/A ________________________________________________________________________________ Item 9. Notice of Dissolution of Group. N/A ________________________________________________________________________________ Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect.
<PAGE> SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 12, 1999 (Date) /s/ Assunta DiLorenzo ---------------------------------------- (Signature) Vice President Legal Affairs & Corporate Secretary (Name/Title) Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties for whom copies are to be sent. Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001).